A detailed history of Ausdal Financial Partners, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Ausdal Financial Partners, Inc. holds 14,967 shares of PFE stock, worth $443,921. This represents 0.05% of its overall portfolio holdings.

Number of Shares
14,967
Previous 13,985 7.02%
Holding current value
$443,921
Previous $388,000 7.73%
% of portfolio
0.05%
Previous 0.05%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$25.26 - $29.6 $24,805 - $29,067
982 Added 7.02%
14,967 $418,000
Q1 2024

Apr 12, 2024

BUY
$25.89 - $29.73 $24,310 - $27,916
939 Added 7.2%
13,985 $388,000
Q4 2023

Jan 11, 2024

SELL
$26.13 - $33.94 $174,574 - $226,753
-6,681 Reduced 33.87%
13,046 $375,000
Q3 2023

Nov 08, 2023

SELL
$32.09 - $37.51 $29,201 - $34,134
-910 Reduced 4.41%
19,727 $654,000
Q2 2023

Jul 31, 2023

SELL
$36.12 - $41.79 $6,357 - $7,355
-176 Reduced 0.85%
20,637 $756,000
Q1 2023

May 04, 2023

SELL
$39.39 - $51.28 $31,354 - $40,818
-796 Reduced 3.68%
20,813 $849,000
Q4 2022

Feb 03, 2023

SELL
$41.75 - $54.5 $1,002 - $1,308
-24 Reduced 0.11%
21,609 $1.11 Million
Q3 2022

Nov 09, 2022

BUY
$43.76 - $53.42 $37,764 - $46,101
863 Added 4.16%
21,633 $947,000
Q2 2022

Aug 09, 2022

SELL
$46.53 - $55.17 $29,872 - $35,419
-642 Reduced 3.0%
20,770 $1.09 Million
Q1 2022

May 04, 2022

SELL
$45.75 - $56.69 $194,574 - $241,102
-4,253 Reduced 16.57%
21,412 $1.11 Million
Q4 2021

Feb 08, 2022

SELL
$41.32 - $61.25 $46,195 - $68,477
-1,118 Reduced 4.17%
25,665 $1.52 Million
Q3 2021

Nov 01, 2021

SELL
$39.25 - $50.42 $31,949 - $41,041
-814 Reduced 2.95%
26,783 $1.15 Million
Q2 2021

Jul 19, 2021

BUY
$35.91 - $40.68 $41,332 - $46,822
1,151 Added 4.35%
27,597 $1.08 Million
Q1 2021

May 05, 2021

BUY
$33.49 - $37.77 $82,251 - $92,763
2,456 Added 10.24%
26,446 $958,000
Q4 2020

Feb 01, 2021

SELL
$33.47 - $42.56 $25,571 - $32,515
-764 Reduced 3.09%
23,990 $883,000
Q3 2020

Nov 04, 2020

BUY
$31.75 - $37.25 $233,362 - $273,787
7,350 Added 42.23%
24,754 $908,000
Q2 2020

Aug 06, 2020

BUY
$30.12 - $36.54 $56,354 - $68,366
1,871 Added 12.05%
17,404 $569,000
Q1 2020

May 04, 2020

BUY
$27.03 - $38.62 $92,875 - $132,698
3,436 Added 28.4%
15,533 $560,000
Q4 2019

Feb 14, 2020

SELL
$32.92 - $37.36 $69,329 - $78,680
-2,106 Reduced 14.83%
12,097 $455,000
Q3 2019

Nov 19, 2019

SELL
$32.49 - $42.13 $82,004 - $106,336
-2,524 Reduced 15.09%
14,203 $510,000
Q2 2019

Aug 05, 2019

SELL
$36.98 - $41.52 $4,918 - $5,522
-133 Reduced 0.79%
16,727 $649,000
Q1 2019

May 13, 2019

BUY
$37.5 - $41.2 $18,712 - $20,558
499 Added 3.05%
16,860 $716,000
Q4 2018

Feb 11, 2019

SELL
$38.47 - $43.86 $324,532 - $370,002
-8,436 Reduced 34.02%
16,361 $714,000
Q3 2018

Nov 09, 2018

BUY
$34.47 - $41.81 $5,411 - $6,564
157 Added 0.64%
24,797 $1.09 Million
Q2 2018

Aug 08, 2018

BUY
$32.98 - $35.16 $118,299 - $126,118
3,587 Added 17.04%
24,640 $894,000
Q1 2018

Apr 20, 2018

SELL
$31.91 - $37.02 $32,292 - $37,464
-1,012 Reduced 4.59%
21,053 $747,000
Q4 2017

Feb 08, 2018

SELL
$33.26 - $35.29 $42,506 - $45,100
-1,278 Reduced 5.47%
22,065 $799,000
Q3 2017

Oct 31, 2017

BUY
$31.0 - $34.15 $723,633 - $797,163
23,343
23,343 $833,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $166B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Ausdal Financial Partners, Inc. Portfolio

Follow Ausdal Financial Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ausdal Financial Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ausdal Financial Partners, Inc. with notifications on news.